Amyloid Beta Exposure on Olfactory Ensheathing Cells Induces Different Expression Pattern of Tissue Transglutaminase and Its Isoforms: Modulatory Effect of Indicaxanthin

Background Alzhèimer Disease (AD) is characterized by intracellular and extracellular protein aggregates in the brain, including amyloid-beta (Aβ). Aβ is a substrate for tissue transglutaminase (TG2), an ubiquitarian calcium-dependent protein that induces Aβ oligomerization and aggregation. We assessed the effect of full native peptide of Aβ(1–42), the fragments (25–35 and 35–25) on TG2 expression levels and its isoforms (Long and Short) on Olfactory Ensheathing Cells (OECs). The levels of cytoskeletal proteins, Vimentin and Glial Fibrillary Acid Protein (GFAP), were also studied. The effect of the pre-treatment with Indicaxanthin on cell viability, total Reactive Oxygen Species (ROS), superoxide anion (O2−) and apoptotic pathway activation was assessed. Since Nestin is co-expressed in pluripotent stem cells with cyclin D1, their levels were evaluated. Methods Mouse primary OECs were exposed to 10 µM Aβ(1–42) or Aβ(25–35) or Aβ(35–25) for 24 h both in the absence and in the presence of Indicaxanthin. TG2 and its isoforms were evaluated through Confocal Laser Scanning Microscopy and Western Blot analysis. Data were statistically analysed using one-way analysis of variance followed by post hoc Holm–Sidak. Results Our findings highlight that OEC exposure to Aβ(1–42) and its fragments induced an increase of TG2 levels and the different expression pattern of its isoforms. Indicaxanthin pre-treatment reduced TG2 over-expression differently modulating its isoforms, following Aβ exposure of the cells. It was also able to prevent total ROS and O2−production, to reduce GFAP and Vimentin levels, inhibiting apoptotic pathway activation. It also leaded to an increase of Nestin and cyclin D1 expression levels. Conclusions Our results show that Aβ exposure on OECs induces an increase of TG2 levels and a different expression pattern of its isoforms and that Indicaxanthin pre-treatment stimulates OEC self-renewal through the reparative activity played by TG2. They also suggest that Aβ in OECs, both in the absence and in the presence of Indicaxanthin, might differently induce the transition of TG2 between “closed” and “open” conformation, providing a new mechanism involved in the signal pathways activated by the protein in Aβ injury important for neural regeneration of AD.

[1]  A. Campisi,et al.  Synergic pro-apoptotic effects of Ferulic Acid and nanostructured lipid carrier in glioblastoma cells assessed through molecular and Delayed Luminescence studies , 2020, Scientific Reports.

[2]  A. M. Almerico,et al.  Indicaxanthin, a multi-target natural compound from Opuntia ficus-indica fruit: From its poly-pharmacological effects to biochemical mechanisms and molecular modelling studies. , 2019, European journal of medicinal chemistry.

[3]  R. Martins,et al.  Autophagy Modulation as a Treatment of Amyloid Diseases , 2019, Molecules.

[4]  L. Tesoriere,et al.  Brain Distribution and Modulation of Neuronal Excitability by Indicaxanthin From Opuntia Ficus Indica Administered at Nutritionally-Relevant Amounts , 2018, Front. Aging Neurosci..

[5]  J. C. Kim,et al.  Topographic Organization of Hippocampal Inputs to the Anterior Olfactory Nucleus , 2018, Front. Neuroanat..

[6]  Pedro Luiz Rosalen,et al.  Exploration of avocado by-products as natural sources of bioactive compounds , 2018, PloS one.

[7]  M. Morbidelli,et al.  NMR Metabolomics for Stem Cell type discrimination , 2017, Scientific Reports.

[8]  P. Reddy,et al.  Therapeutics of Neurotransmitters in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[9]  Qing X. Yang,et al.  Central Olfactory Dysfunction in Alzheimer's Disease and Mild Cognitive Impairment: A Functional MRI Study. , 2017, Journal of Alzheimer's disease : JAD.

[10]  A. Campisi,et al.  Effect of Some Growth Factors on Tissue Transglutaminase Overexpression Induced by β-Amyloid in Olfactory Ensheathing Cells , 2017, Molecular Neurobiology.

[11]  E. Hol,et al.  Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease , 2016, Progress in Neurobiology.

[12]  S. Kojima,et al.  Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death , 2016, Cell Death and Disease.

[13]  Jingwen Zhang,et al.  The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability* , 2016, The Journal of Biological Chemistry.

[14]  V. Silani,et al.  Phenotypic Modulation and Neuroprotective Effects of Olfactory Ensheathing Cells: a Promising Tool for Cell Therapy , 2015, Stem Cell Reviews and Reports.

[15]  T. Psaltopoulou,et al.  Mediterranean Diet and Risk of Dementia. , 2015, Current Alzheimer research.

[16]  A. M. Almerico,et al.  Indicaxanthin from Opuntia ficus-indica Crosses the Blood-Brain Barrier and Modulates Neuronal Bioelectric Activity in Rat Hippocampus at Dietary-Consistent Amounts. , 2015, Journal of agricultural and food chemistry.

[17]  Shiaw-Min Hwang,et al.  Cyclin D1 acts as a barrier to pluripotent reprogramming by promoting neural progenitor fate commitment , 2014, FEBS letters.

[18]  P. Mecocci,et al.  Nutraceuticals in cognitive impairment and Alzheimer’s disease , 2014, Front. Pharmacol..

[19]  K. Jellinger,et al.  Olfactory bulb involvement in neurodegenerative diseases , 2014, Acta Neuropathologica.

[20]  P. Rudrabhatla Regulation of neuronal cytoskeletal protein phosphorylation in neurodegenerative diseases. , 2014, Journal of Alzheimer's disease : JAD.

[21]  C. Gentile,et al.  Phytochemical indicaxanthin suppresses 7-ketocholesterol-induced THP-1 cell apoptosis by preventing cytosolic Ca2+ increase and oxidative stress , 2012, British Journal of Nutrition.

[22]  Giuseppina Raciti,et al.  Expression of tissue transglutaminase on primary olfactory ensheathing cells cultures exposed to stress conditions , 2012, Neuroscience Research.

[23]  S. Kojima,et al.  New insights into the functions and localization of nuclear transglutaminase 2 , 2011, The FEBS journal.

[24]  D. Zaccheo,et al.  Biomarkers expression in rat olfactory ensheathing cells. , 2010, Frontiers in bioscience.

[25]  D. Zaccheo,et al.  Olfactory ensheathing cells represent an optimal substrate for hippocampal neurons: an in vitro study , 2009, International Journal of Developmental Neuroscience.

[26]  Howard Chertkow,et al.  Olfaction in patients with mild cognitive impairment and Alzheimer's disease , 2008, Neurobiology of Aging.

[27]  J. Verhaagen,et al.  Olfactory ensheathing glia: Their contribution to primary olfactory nervous system regeneration and their regenerative potential following transplantation into the injured spinal cord , 2007, Brain Research Reviews.

[28]  G. Melino,et al.  Transglutaminase 2 Kinase Activity Facilitates Protein Kinase A-induced Phosphorylation of Retinoblastoma Protein* , 2007, Journal of Biological Chemistry.

[29]  R. Pellitteri,et al.  Olfactory ensheathing cells exert a trophic effect on the hypothalamic neurons in vitro , 2007, Neuroscience Letters.

[30]  M. Endo,et al.  Two isoforms of tissue transglutaminase mediate opposing cellular fates , 2006, Proceedings of the National Academy of Sciences.

[31]  G. Li Volti,et al.  Glutamate‐evoked redox state alterations are involved in tissue transglutaminase upregulation in primary astrocyte cultures , 2004, FEBS letters.

[32]  G. Johnson,et al.  Intracellular Localization and Activity State of Tissue Transglutaminase Differentially Impacts Cell Death* , 2004, Journal of Biological Chemistry.

[33]  Masashi Kikuchi,et al.  A novel function of tissue-type transglutaminase: protein disulphide isomerase. , 2003, The Biochemical journal.

[34]  G. Raciti,et al.  Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells , 2003, Brain Research.

[35]  S. Weintraub,et al.  Anti-apoptotic proteins are oxidized by Abeta25-35 in Alzheimer's fibroblasts. , 2003, Biochimica et biophysica acta.

[36]  K. Santacruz,et al.  Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration , 2002, Neurochemistry International.

[37]  G. Johnson,et al.  Tissue transglutaminase: a possible role in neurodegenerative diseases , 2000, Progress in Neurobiology.

[38]  R. Graham,et al.  Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. , 1994, Science.

[39]  M. Chuah,et al.  Cultures of ensheathing cells from neonatal rat olfactory bulbs , 1993, Brain Research.